Mental Health

Once Spravato is determined as an appropriate treatment option, in accordance with the REMS, the patient will be treated at a certified treatment center that is trained to administer the medicine and address patient needs.

Flouxetine tablets were approved with the indication of treating multiple mental disorders.

The FDA has approved marketing of Lupin Pharmaceuticals’ Lurasidone Hydrochloride Tablets, a generic version of Sunovion Pharmaceuticals, Inc's lurasidone HCl (Latuda) tablets.

Top news of the day across the health care landscape.

How can pharmacists implement nonpharmacologic treatments for patients with dementia?

In this video, David Hager, PharmD, BCPS, the director of clinical pharmacy services at UW Health, Madison, WI, discusses the relationship between burnout and depression.

Stigma surrounding mental illnesses can prevent people from seeking treatment.

Majority of older patients with cancer and those who survived the disease found to have high levels of social and psychological wellbeing.

Public action to prevent suicide becomes crucial, as suicide rates rise in almost every state.

The results of a recent study show that persistent postnatal depression lasting 6 months or longer can have severe implications on child development.

Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects, and blood sugar disturbances.

Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects and blood sugar disturbances, according to a press release

The updated labeling will strengthen warnings for mental health adverse effects and risks related to hypoglycemia.

New research suggests psychiatric diseases that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.

Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company.

The deaths this week of Kate Spade and Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented.

This adult fantasy game provides a first-hand view of psychosis and the symptoms its patients often experience.

Dextromethorphan neuroprotective characteristics may play a role in patients with bipolar disorder.

Lamotrigine (Lamictal) for seizures and bipolar disorder can cause hemophagocytic lymphohistiocytosis (HLH), a rare, but very serious immune system reaction that excessively activates the body’s infection-fighting immune system.

Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age).

Experts are finding, though, that burnout doesn't limit its impact to the workplace. It also impacts parts of your life that extend well beyond the pharmacy.

Discover how a mindfulness practice can improve a person's quality of life.

Infectious disease and HIV specialists may be more willing to prescribe HIV preexposure prophylaxis than primary care providers.

Officials with Allergan and Gedeon Richter are reporting positive topline results for a phase 3 study of cariprazine (Vraylar) for the treatment of adults with bipolar I depression.

Children with HIV have a unique risk of nonadherence in adolescence and elevated risk of mental health and substance use problems later in life.

Adolescents and young adults who are living with HIV and were exposed to the virus perinatally have a unique risk of nonadherence in adolescence, as well as an elevated risk of mental health and substance use problems.

Here are some ways to cope with any stress or challenges that community pharmacy may bring.

One glaring omission is the lack of psychiatric medications included.

With the smart tablets coming to market in 2018, it is a good time to explore how the technology behind the product works.

Aripiprazole tablets with sensor (Abilify MyCite) is approved to treat schizophrenia, manic and mixed episodes for patients with bipolar I disorder, and as an add-on for depression treatment.